序号 |
标题 |
次数 |
作者 |
发布时间 |
86491 |
DOTA-PEG-biotin DOTA-聚乙二醇-生物素 |
93 |
zcy |
2024-11-22 |
86492 |
DOTA-PEG(23)-bromoacetamide*2TFA |
103 |
zyl |
2024-11-22 |
86493 |
CAS号:219143-29-0,DOTA-(MeAm)4 |
104 |
kx |
2024-11-22 |
86494 |
DOTA(tBu3)-PEG(4)-TFP |
99 |
zyl |
2024-11-22 |
86495 |
DOTA-MBP 齐岳定制 |
114 |
zcy |
2024-11-22 |
86496 |
CAS号:293295-66-6,Y-DOTA-TOC |
90 |
kx |
2024-11-22 |
86497 |
CAS:2792156-83-1 IPB-K(DOTA)-FAPI |
97 |
zyl |
2024-11-22 |
86498 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸-Ser-Ser-Ser-LTVSPWY |
110 |
zcy |
2024-11-22 |
86499 |
CAS号:474424-15-2,dota-pnp |
103 |
kx |
2024-11-22 |
86500 |
CU-64 DOTA-TATE |
114 |
zyl |
2024-11-22 |
86501 |
DOTA-hLL2 螯合剂DOTA偶联人源化抗体hLL2 |
119 |
zcy |
2024-11-22 |
86502 |
DOTA-PSMA-EB-01 |
103 |
zyl |
2024-11-22 |
86503 |
1610950-41-8,DOTA-MeTz,DOTA-甲基四嗪 |
103 |
kx |
2024-11-22 |
86504 |
p-NCS-benzyl-DOTA p-NCS-苄基-DOTA |
151 |
zcy |
2024-11-22 |
86505 |
1189194-64-6,DOTA-(COOt-Bu)3-CH2-Alkynyl |
87 |
kx |
2024-11-22 |
86506 |
DOTA-cyclo(RGDfK);DOTA-RGD |
101 |
wyh |
2024-11-22 |
86507 |
CuAAC修饰的DOTAZA 齐岳定制 |
124 |
zcy |
2024-11-22 |
86508 |
1039726-31-2,DOTA-JR-11 |
88 |
kx |
2024-11-22 |
86509 |
zher2-HSA-DOTA DOTA螯合剂偶联ZHER2支架多肽缀合人血清白蛋白 |
131 |
zcy |
2024-11-22 |
86510 |
CAS:1800229-46-2 Maleimide-DOTA-GA |
100 |
zyl |
2024-11-22 |
86511 |
panitumumab-DOTA DOTA标记的抗EGFR帕尼单抗 |
100 |
zcy |
2024-11-22 |
86512 |
DOTA-CH2-Ph-azide(HCl salt) |
97 |
kx |
2024-11-22 |
86513 |
DOTA-三(酸) - 酰氨基-DPEG(R)11-马来酰亚胺 |
113 |
zyl |
2024-11-22 |
86514 |
DOTA-Glu「cyclo(Arg-Gly-Asp-D-Phe-Lys)」2 |
102 |
kx |
2024-11-22 |
86515 |
CAS:834870-39-2 DOTA series |
111 |
zyl |
2024-11-22 |
86516 |
DOTA-cyclo(RGDfK);DOTA-RGD |
103 |
wyh |
2024-11-22 |
86517 |
DOTA-PEG-SH、DOTA-PEG-Thiol的结构组成 |
99 |
kx |
2024-11-22 |
86518 |
DTPA-bis anhydride,二亚乙基三胺五乙酸二酐 |
113 |
wyh |
2024-11-22 |
86519 |
NOTA-PEG5000-Mal ;NOTA PEG5 马来酰亚胺 |
83 |
wyh |
2024-11-22 |
86520 |
DOTA-E「c(RGDfK)2」 |
92 |
kx |
2024-11-22 |
86521 |
DOTA-L-Lys(SA。Pam)-PSMA-617 DOTA偶联二膦酸盐和PSMA抑制剂 |
108 |
zcy |
2024-11-22 |
86522 |
DOTA-E[c(RGDfK)2]的应用领域 |
116 |
kx |
2024-11-22 |
86523 |
DOTA-氟喹诺酮衍生物 DOTA-fluoroquinolone derivatives |
89 |
zcy |
2024-11-22 |
86524 |
DOTA-NHS |
158 |
kx |
2024-11-22 |
86525 |
p-SCN-Bn-DTPA,102650-30-6,1-(4-异硫氰酸酯)二乙炔三胺 |
96 |
wyh |
2024-11-22 |
86526 |
NOTA-PEG-RGD |
91 |
kx |
2024-11-22 |
86527 |
三叔丁基1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸;137076-54-1 |
125 |
wyh |
2024-11-22 |
86528 |
DOTA-PEG-CRGD的结构组成、应用领域 |
89 |
kx |
2024-11-22 |
86529 |
DOTA-MWCNT-Gd DOTA钆配合物修饰多壁碳纳米管 |
91 |
zcy |
2024-11-22 |
86530 |
817562-90-6,(R)-tert-Bu4-DOTAGA,(R)-DOTAGA-四叔丁酯 |
85 |
kx |
2024-11-22 |
86531 |
DOTA-四聚乙二醇-甲基四嗪 |
105 |
zyl |
2024-11-22 |
86532 |
DOTA-奥曲肽,DOTA-octreotide |
120 |
kx |
2024-11-22 |
86533 |
DOTA-五聚乙二醇-C4-二苯并环辛炔 |
77 |
zyl |
2024-11-22 |
86534 |
127985-74-4 ,p-SCN-Bn-DOTA |
106 |
kx |
2024-11-22 |
86535 |
DOTA-Glu[cyclo(Arg-Gly-Asp-D-Phe-Lys)]2,250612-06-7 |
88 |
wyh |
2024-11-22 |